RE: mlk14 Jan 2021 12:03
Nasdaq closed
This was posted by Bobbybingo on here last night.
'I just read this article in arm chair trader, from an interview with GC on 7th Jan, note the dates in the last paragraph, excellent news for next week. here is the part that matters.
Monoclonal antibody market is worth billions of dollars
Foralumab, the drug that has just completed clinical trials in Brazil, is a human monoclonal antibody. Human monoclonal antibody, the world’s first, is an antibody cloned from a single cell and has proven more successful than a monoclonal antibody developed from mice, which the human body rejects more frequently. The monoclonal antibody market is worth multiple billions of dollars as it can be used to treat not only COVID and Chron’s disease but also diabetes, multiple sclerosis and other major illnesses. A successful drug in this space, particularly one that can be used fairly easily in form of a nasal spray, would have massive first mover advantage.
Further information about the state of its pipeline could be provided on 18 January when the company will publish its prospectus ahead of its first trading day on the London Stock Exchange on 21 January.'
Wasn't the prospectus published in December? If US of A is closed, would they wait until Tues to update the market here?
BB